fbpx

Valeant Pharmaceuticals Appoints BARKER as AOR

by | Nov 29, 2017

New York-based independent advertising agency BARKER announced that it has been named the agency of record for a new brand launch through Valeant Pharmaceuticals International, Inc.‘s wholly owned subsidiary, Bausch + Lomb, a leading global eye health organization.

The account was awarded after a formal review, and BARKER will develop and produce an integrated campaign which will be implemented across TV, Print, digital and social media channels, in spring 2018.

“We were impressed with BARKER’s approach to how we will create breakthrough and provocative work together,” said Chris Marschall, VP of Marketing, Bausch + Lomb. “BARKER proved to be the agency best-equipped to create new consumer behavior that will ultimately make this product launch successful.”

“BARKER couldn’t be prouder to announce our partnership with Bausch + Lomb,” said John Barker, Founder and Chief Idea Officer. “This new relationship can push creative boundaries while incorporating best practice in learning in CPG and OTC consumer healthcare.”

Daily PR Updates

Essential PR industry news, opinion, and analysis delivered to your inbox daily.

Bulldog Reporter
Bulldog Reporter is a leader in media intelligence supplying news, analysis and high-level training content to public relations and corporate communications professionals with the mission of helping these practitioners achieve superior competitive performance.

RECENT ARTICLES